Not Just Endocarditis: Hospitalizations for Selected Invasive Infections Among Persons With Opioid and Stimulant Use Diagnoses-North Carolina, 2010-2018

J Infect Dis. 2020 Sep 2;222(Suppl 5):S458-S464. doi: 10.1093/infdis/jiaa129.

Abstract

Background: While increases in overdoses, viral hepatitis, and endocarditis associated with drug use have been well-documented in North Carolina, the full scope of invasive drug-related infections (IDRIs) has not. We characterized trends in IDRIs among hospitalized patients in North Carolina.

Methods: We compared invasive infections that were related or not related to drug use among hospitalized patients aged 18-55 years based on retrospective review of administrative records from 2010-2018. Hospitalizations for endocarditis, central nervous system/spine infections, osteomyelitis, and septic arthritis were labeled as IDRIs if discharge codes included opioid and/or amphetamine misuse. Trends, rates, and distributions were calculated.

Results: Among 44 851 hospitalizations for the specified infections, 2830 (6.3%) were IDRIs. The proportion of infections attributable to drug use increased from 1.5% (2010) to 13.1% (2018), and the rate grew from 1.2 to 15.1 per 100 000. Compared with those who had non-drug-related infections, patients with IDRIs were younger (median age, 35 vs 46 years), more likely to be non-Hispanic white (81% vs 56%), and had longer hospitalizations (median, 8 vs 6 days). 43% of hospitalizations for IDRIs involved infective endocarditis.

Conclusions: The rate of IDRIs in North Carolina increased substantially during 2010-2018, indicating an urgent need for enhanced infection prevention, harm reduction, and addiction services aimed at community and inpatient settings.

Keywords: amphetamine misuse; drug-related infection; injection drug use; opioid misuse; people who inject drugs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Age Factors
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / adverse effects
  • Arthritis, Infectious / epidemiology*
  • Arthritis, Infectious / microbiology
  • Arthritis, Infectious / prevention & control
  • Central Nervous System Infections / epidemiology*
  • Central Nervous System Infections / microbiology
  • Central Nervous System Infections / prevention & control
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / adverse effects
  • Drug Users / statistics & numerical data
  • Endocarditis, Bacterial / epidemiology*
  • Endocarditis, Bacterial / microbiology
  • Endocarditis, Bacterial / prevention & control
  • Female
  • Humans
  • Incidence
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • North Carolina / epidemiology
  • Osteomyelitis / epidemiology*
  • Osteomyelitis / microbiology
  • Osteomyelitis / prevention & control
  • Retrospective Studies
  • Risk Factors
  • Substance Abuse, Intravenous / complications*
  • White People / statistics & numerical data

Substances

  • Analgesics, Opioid
  • Central Nervous System Stimulants